Group Mafra’s Acquisition Of Byogene


Pinheiro Guimarães advised Group Mafra Hospitalar, while Boccuzzi Advogados advised the selling shareholders in the transaction.

Group Mafra Hospitalar executed the acquisition of Byogene for an undisclosed amount.

Byogene is a strategic authorized distributor of Roche Diagnóstica in the State of São Paulo, Brazil. Byogene’s operations will be integrated to Mafra’s specialized division focused on diagnosis solutions and will reinforce Group Mafra’s market position as a leader in the distribution of medicines, equipment, diagnosis solutions and hospital materials in Brazil, with over R$3 billion in annual revenues.

Pinheiro Guimarães advised Group Mafra Hospitalar, with a team led by partner Rodrigo Marcilio (Picture) and associates Carolina Cardoso Ramalho, Isis Faria, Caio Ferreira and Alexandre Vendramini.

Boccuzzi Advogados advised the selling shareholders, with a team led by partner Marco Orlandi.

Involved fees earner: Marco Ferreira Orlandi – Boccuzzi Advogados; Carolina Cardoso Ramalho – Pinheiro Guimarães; Caio Ferreira – Pinheiro Guimarães; Isis Garcia de Faria – Pinheiro Guimarães; Rodrigo Marcilio – Pinheiro Guimarães; Alexandre Vendramini – Pinheiro Guimarães;

Law Firms: Boccuzzi Advogados; Pinheiro Guimarães;

Clients: Byogene; Mafra Hospitalar;